Diagnostic radiographic silver halide photographic film material
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 11, 2004
Grant Date -
Jan 15, 2004
app pub date -
Jun 30, 2003
filing date -
Jul 5, 2002
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
A single-side coated silver halide photographic film material has been disclosed, said film material comprising a support, at least one light-sensitive emulsion layer and a substantially light-insensitive protective hydrophilic colloid layer farther away from said support than said emulsion layer, wherein said emulsion layer contains a silver halide emulsion rich in silver bromide with cubic crystals having an average numerical diameter in the range from 0.4 up to 0.8 .mu.m, wherein at least 95 mole % of bromide ions are present, and wherein said hydrophilic colloid layer or another substantially light-insensitive hydrophilic colloid layer essentially comprises a hydrazide represented by the general formula (I) having a silver halide adsorbing group or a masked silver halide adsorbing group; besides a method for forming a diagnostic image comprising the steps of contacting said photographic film material with an intensifying screen, forming a film/screen assembly, and exposing said assembly to X-ray radiation with an energy lower than or equal to 70 kVp, and processing said film material during a time of 90 seconds or less in a processing cycle following the steps of developing, fixing, rinsing and drying, and wherein the developing proceeds in a radiographic developer composition essentially comprising a hydroquinone and a phenidone (a 1-phenyl-3-pyrazolidine-1-one compound) as a developing agent and a heteroatomic nitro-indazol.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
AGFA HEALTHCARE | 2640 MORTSEL |
International Classification(s)

- 2003 Application Filing Year
- G03C Class
- 795 Applications Filed
- 175 Patents Issued To-Date
- 22.02 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Callant, Paul | Edegem, BE | 59 | 236 |
# of filed Patents : 59 Total Citations : 236 | |||
De, Bie Leo | Mortsel, BE | 1 | 1 |
# of filed Patents : 1 Total Citations : 1 | |||
Joly, Ludo | Hove, BE | 15 | 102 |
# of filed Patents : 15 Total Citations : 102 | |||
Loccufier, Johan | Zwijnaarde, BE | 303 | 1577 |
# of filed Patents : 303 Total Citations : 1577 | |||
Van, den Zegel Marc | Boortmeerbeek, BE | 12 | 43 |
# of filed Patents : 12 Total Citations : 43 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- G03C Class
- 5.41 % this patent is cited more than
- 21 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
